Hidradenitis Suppurativa (HS) Tunneling Wounds
Recruiting in Palo Alto (17 mi)
Overseen byHadar Lev-Tov, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Miami
No Placebo Group
Trial Summary
What is the purpose of this trial?
The purpose of this study is to look at the change in the microbiome (bacterial composition) of an HS tunneling wound and examine if treatment with an antibiofilm surfactant wound gel (ABWG) (a topical medication that will fight bacteria attached to the surface of those tunnels) changes the bacterial composition of the wounds.
Eligibility Criteria
Inclusion Criteria
Have diagnosis of HS confirmed by a dermatologist
Have at least one HS related tunneling wound that is at least 2 centimeters in length
Able to provide informed consent
See 1 more
Treatment Details
Interventions
- ABWG (Antibacterial Agent)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ABWGExperimental Treatment1 Intervention
The participants in this group will be receiving the ABWG daily for 4 consecutive weeks.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of MiamiMiami, FL
Loading ...
Who Is Running the Clinical Trial?
University of MiamiLead Sponsor
Next Science LLCCollaborator